According to the Official Journal of the European Union, on November 12, 2024, the European Commission published Regulation (EU) 2024/2848, amending the approval period for fenpyrazamine and Flumetralin, which will enter into force on the 20th day from the date of publication.

According to the regulations, the approval period of fenpyrazamine and Flumetralin is revised to January 15, 2025.